Study Once More Underpins The Clinical Value Of FDA-Cleared Breast Cancer Recurrence

[News]

Agendia, a world leader in molecular cancer diagnostics, announced recently that together with several groups of scientific collaborators it has identified a major role for TSPYL5, one of its MammaPrint breast cancer prognosis genes, in the genesis of breast cancer...

More... (http://mnt.to/f/3PnY)